Immunity to and Prevention of Herpes Zoster

Inbunden, Engelska, 2001

AvA. A. Gershon,Charles H. Calisher,Anne A. Gershon,Charles H. Calisher,Ann M. Arvin

1 709 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Finns i fler format (1)

Häftad

749 kr

Skickas inom 10-15 vardagar

Varicella-zoster virus (VZV) causes both chickenpox and zoster. Fundamental to their prevention is an understanding of the natural history of VZV infection. This is a compilation of papers presented in March 1999 in Osaka, Japan, by internationally renowned researchers studying varicella-zoster virus and a vaccine used to prevent disease caused by this virus. The aim of the meeting was to explore progress made in basic and molecular biology of VZV and current understanding of latent infection and reactivation. Data concerning immune responses to VZV, mechanisms by which virus latency are controlled, and the latest information on vaccination to prevent varicella and zoster are presented and discussed.

Produktinformation

Utgivningsdatum2001-03-28
Mått210 x 279 x 17 mm
Vikt780 g
FormatInbunden
SpråkEngelska
Antal sidor185
FörlagSpringer Verlag GmbH
ISBN9783211835562

Tillhör följande kategorier

Dermatologi inom Medicin
Patologi inom Medicin

The current status of live attenuated varicella vaccine (Gershon, A. A.); Evidence for frequent reactivation of the Oka varicella vaccine strain in healthy vaccines (Krause, P. R.); Investigation of varicella-zoster virus variation by heteroduplex mobility assay (Barrett-Muir, W., Hawrami, K., Clarke, J., Breuer, J.); Varicella-zoster virus with a lost gE epitope: evidence for immunological pressure by the human antibody response (Padilla, J. A., Grose, C.); Biologic and geographic differences between vaccine and clinical varicella-zoster virus isolates (LaRussa, P. S., Gershon, A. A.); Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses (Gomi, Y., Imagawa, T., Takahashi, M., Yamanishi, K.); Cis and trans elements regulating expression of the varicella-zoster virus gI gene (He, H., Boucaud, D., Hay, J., Ruyechan, W. T.); Interactions among structural proteins of varicella-zoster virus (Spengler, M., Niesen, N., Grose, C., Ruyechan, W. T., Hay, J.); The role of varicella-zoster virus immediate-early proteins in latency and their potential use as components of vaccines (Sadzot-Delvaux, C., Rentier, B.); Mutagenesis of the varicella-zoster virus genome: lessons learned (Cohen, J. I.); Immune evasion mechanisms of varicella-zoster virus (Abendroth, A., Arvin, A.); Pathway of viral spread in herpes zoster: detection of the protein encoded by open reading frame 63 of varicella-zoster virus in biopsy specimens (Iwasaki, T., Muraki, R., Kasahara, T., Sato, Y., Sata, T., Kurata, T.); Vaccination against cytomegalovirus (Plotkin, S. A.); Varicella-zoster virus in human and rat tissue specimens (Annunziato, P. W., Lungu, O., Panagiotidis, C.); In vitro measurement of human T cell responses to varicella-zoster virus antigen (Hayward, A. R.); Use of varicella vaccines to prevent herpes zoster in older individuals (Levin, M. J.); Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction (Takahashi, M., Kamiya, H., Asano, Y., Shiraki, K., Baba, K., Otsuka, T., Hirota, T., Yamanishi, K.); Varicella-zoster virus immunity and prevention: a conference perspective (Straus, S. E.).

Du kanske också är intresserad av

Herpes Zoster: Postherpetic Neuralgia and Other Complications

C. Peter N. Watson, Anne A. Gershon, Michael N. Oxman

Inbunden, 2017

1 489 kr

Herpes Zoster: Postherpetic Neuralgia and Other Complications

C. Peter N. Watson, Anne A. Gershon, Michael N. Oxman

Häftad, 2018

1 629 kr

Viral Gastroenteritis

Shunzo Chiba, Mary K. Estes, Shuji Nakata, Charles H. Calisher

Häftad, 1997

749 kr

African Horse Sickness

Philip S. Mellor, Matthew Baylis, Christopher Hamblin, Charles H. Calisher, Peter P.C. Mertens

Häftad, 1998

2 969 kr

Emergence and Control of Zoonotic Viral Encephalitides

Charles H. Calisher, Diane E. Griffin

Häftad, 2004

2 229 kr

Del 438

Varicella-zoster Virus

Ann M. Arvin, Jennifer F. Moffat, Allison Abendroth, Stefan L Oliver

Häftad, 2023

2 369 kr

Del 438

Varicella-zoster Virus

Ann M. Arvin, Jennifer F. Moffat, Allison Abendroth, Stefan L Oliver

Inbunden, 2022

2 369 kr

Del 342

Varicella-zoster Virus

Allison Abendroth, Ann M. Arvin, Jennifer F. Moffat

Häftad, 2012

3 599 kr

Del 18

Emergence and Control of Zoonotic Viral Encephalitides

Charles H. Calisher, Diane E. Griffin

Inbunden, 2004

2 229 kr

Del 342

Varicella-zoster Virus

Allison Abendroth, Ann M. Arvin, Jennifer F. Moffat

Inbunden, 2010

3 599 kr

Immunity to and Prevention of Herpes Zoster

Inbunden, Engelska, 2001

AvA. A. Gershon,Charles H. Calisher,Anne A. Gershon,Charles H. Calisher,Ann M. Arvin

1 709 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Finns i fler format (1)

Häftad

749 kr

Skickas inom 10-15 vardagar

Produktinformation

Utgivningsdatum2001-03-28
Mått210 x 279 x 17 mm
Vikt780 g
FormatInbunden
SpråkEngelska
Antal sidor185
FörlagSpringer Verlag GmbH
ISBN9783211835562

Tillhör följande kategorier

Dermatologi inom Medicin
Patologi inom Medicin

The current status of live attenuated varicella vaccine (Gershon, A. A.); Evidence for frequent reactivation of the Oka varicella vaccine strain in healthy vaccines (Krause, P. R.); Investigation of varicella-zoster virus variation by heteroduplex mobility assay (Barrett-Muir, W., Hawrami, K., Clarke, J., Breuer, J.); Varicella-zoster virus with a lost gE epitope: evidence for immunological pressure by the human antibody response (Padilla, J. A., Grose, C.); Biologic and geographic differences between vaccine and clinical varicella-zoster virus isolates (LaRussa, P. S., Gershon, A. A.); Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses (Gomi, Y., Imagawa, T., Takahashi, M., Yamanishi, K.); Cis and trans elements regulating expression of the varicella-zoster virus gI gene (He, H., Boucaud, D., Hay, J., Ruyechan, W. T.); Interactions among structural proteins of varicella-zoster virus (Spengler, M., Niesen, N., Grose, C., Ruyechan, W. T., Hay, J.); The role of varicella-zoster virus immediate-early proteins in latency and their potential use as components of vaccines (Sadzot-Delvaux, C., Rentier, B.); Mutagenesis of the varicella-zoster virus genome: lessons learned (Cohen, J. I.); Immune evasion mechanisms of varicella-zoster virus (Abendroth, A., Arvin, A.); Pathway of viral spread in herpes zoster: detection of the protein encoded by open reading frame 63 of varicella-zoster virus in biopsy specimens (Iwasaki, T., Muraki, R., Kasahara, T., Sato, Y., Sata, T., Kurata, T.); Vaccination against cytomegalovirus (Plotkin, S. A.); Varicella-zoster virus in human and rat tissue specimens (Annunziato, P. W., Lungu, O., Panagiotidis, C.); In vitro measurement of human T cell responses to varicella-zoster virus antigen (Hayward, A. R.); Use of varicella vaccines to prevent herpes zoster in older individuals (Levin, M. J.); Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction (Takahashi, M., Kamiya, H., Asano, Y., Shiraki, K., Baba, K., Otsuka, T., Hirota, T., Yamanishi, K.); Varicella-zoster virus immunity and prevention: a conference perspective (Straus, S. E.).